A Database of High-Resolution MS/MS Spectra for Lichen
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Review of Usnic Acid and Usnea Barbata Toxicity
Journal of Environmental Science and Health Part C, 26:317–338, 2008 ISSN: 1059-0501 (Print); 1532-4095 (Online) DOI: 10.1080/10590500802533392 Review of Usnic Acid and Usnea Barbata Toxicity Lei Guo,1 Qiang Shi,1 Jia-Long Fang,1 Nan Mei,1 A. Afshan Ali,1 Sherry M. Lewis,1 Julian E.A. Leakey,1 and Vasilios H. Frankos2 1National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas, USA 2Center for Food Safety and Applied Nutrition, Food and Drug Administration, College Park, Maryland, USA Usnic acid is a prominent secondary lichen metabolite that has been used for vari- ous purposes worldwide. Crude extracts of usnic acid or pure usnic acid have been marketed in the United States as dietary supplements to aid in weight loss. The US Food and Drug Administration (FDA) received 21 reports of liver toxicity re- lated to the ingestion of dietary supplements that contain usnic acid. This prompted the FDA to issue a warning about one such supplement, LipoKinetix, in 2001 (http://www.cfsan.fda.gov/∼dms/ds-lipo. html). Subsequently, usnic acid and Usnea bar- bata lichen were nominated by the National Toxicology Program (NTP) for toxicity eval- uations. At present, a toxicological evaluation of usnic acid is being conducted by the NTP. This review focuses on the recent findings of usnic acid-induced toxicities and their underlying mechanisms of action. Keywords Weight loss dietary supplement; usnic acid and Usnea barbata toxicity INTRODUCTION In the United States, dietary and herbal supplements are extensively used, and under the Dietary Supplement Health and Education Act (DSHEA) of 1994 they are not required to undergo rigorous safety evaluation prior to being marketed. -
Content and Distribution of Usnic Acid Enantiomers in Three Icelandic Lichen Taxa
M.Sc. Thesis in Pharmacy Content and distribution of usnic acid enantiomers in three Icelandic lichen taxa Aron Elvar Gylfason April 2019 Content and distribution of usnic acid enantiomers in three Icelandic lichen taxa Aron Elvar Gylfason M.Sc. Thesis in Pharmacy Administrative Supervisor: Bergþóra Sigríður Snorradóttir Faculty of Pharmaceutical Sciences School of Health Sciences June 2019 i This thesis is for a M.Sc. degree in Pharmacy and may not be reproduced in any form without the written permission of the author. © Aron Elvar Gylfason 2019 Printing: Svansprent ehf. Reykjavík, Iceland 2019 ii Written by Aron Elvar Gylfason Administrative Bergþóra Sigríður Snorradóttir, Ph.D. Supervisor Assistant Professor Faculty of Pharmaceutical Sciences, University of Iceland Supervisor Maonian Xu, Ph.D. Post-doc fellow Faculty of Pharmaceutical Sciences, University of Iceland iii ABSTRACT Content and distribution of usnic acid enantiomers in three Icelandic lichen taxa Drug discovery has changed dramatically over the past years with the advent of new tools in chemical analytics and molecular biology. Successful discovery of new antibiotics, however, is rare. In addition to this, the overuse of antibiotics threatens their effectiveness due to increased resistance. Lichen species were used as traditional medicine prior to the discovery of the penicillin antibiotics and increased multidrug resistance has generated renewed interest in lichens. Usnic acid is one of the most common secondary lichen metabolites and is by far the most extensively studied. The (+)-enantiomer of usnic acid has more potent antimicrobial activity (especially against Gram-positive bacteria) whereas the (-)-enantiomer shows mild antifungal activity and strong phytotoxicity. In contrast to the vast number of papers describing the bioactivity of usnic acid, the characterization of usnic acid enantiomers is lagging behind. -
Introduction (Pdf)
Dictionary of Natural Products on CD-ROM This introduction screen gives access to (a) a general introduction to the scope and content of DNP on CD-ROM, followed by (b) an extensive review of the different types of natural product and the way in which they are organised and categorised in DNP. You may access the section of your choice by clicking on the appropriate line below, or you may scroll through the text forwards or backwards from any point. Introduction to the DNP database page 3 Data presentation and organisation 3 Derivatives and variants 3 Chemical names and synonyms 4 CAS Registry Numbers 6 Diagrams 7 Stereochemical conventions 7 Molecular formula and molecular weight 8 Source 9 Importance/use 9 Type of Compound 9 Physical Data 9 Hazard and toxicity information 10 Bibliographic References 11 Journal abbreviations 12 Entry under review 12 Description of Natural Product Structures 13 Aliphatic natural products 15 Semiochemicals 15 Lipids 22 Polyketides 29 Carbohydrates 35 Oxygen heterocycles 44 Simple aromatic natural products 45 Benzofuranoids 48 Benzopyranoids 49 1 Flavonoids page 51 Tannins 60 Lignans 64 Polycyclic aromatic natural products 68 Terpenoids 72 Monoterpenoids 73 Sesquiterpenoids 77 Diterpenoids 101 Sesterterpenoids 118 Triterpenoids 121 Tetraterpenoids 131 Miscellaneous terpenoids 133 Meroterpenoids 133 Steroids 135 The sterols 140 Aminoacids and peptides 148 Aminoacids 148 Peptides 150 β-Lactams 151 Glycopeptides 153 Alkaloids 154 Alkaloids derived from ornithine 154 Alkaloids derived from lysine 156 Alkaloids -
Risks Associated with Fat Burners a Toxicological Perspective
Food and Chemical Toxicology 123 (2019) 205–224 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Review Risks associated with fat burners: A toxicological perspective T Žiga Jakopin Department of Medicinal Chemistry, Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000, Ljubljana, Slovenia ARTICLE INFO ABSTRACT Keywords: Dietary supplements “fat burners”, freely available on the market, are intended to promote weight loss and Dietary supplements reduce fat accumulation, either via stimulation of lipolysis or by inhibition of lipogenesis. Proponents claim that Fat burners fat burners can increase fat metabolism, although their usefulness remains controversial. Fat burners are usually Mechanism of action claimed to be of natural origin and viewed as being inherently safe. This review focuses on the most common Safety ingredients of natural origin usually found in the fat burners, their molecular mechanisms of action and the Toxicity toxicological profiles of these compounds in order to gain an insight into their safety. Adverse effects 1. Introduction adverse effects have been reported. Sibutramine (noradrenaline and serotonin uptake inhibitor) and fenfluramine (5-HT2C and 5-HT2B re- The proportion of overweight or obese adults has already surpassed ceptor agonist) were withdrawn from the market due to cardiovascular 70% in the US; and 50% in Europe (Fujioka, 2015). Obesity is a com- complications (Connolly et al., 1997; James et al., 2010). Similarly, plex metabolic behavioral disorder that disrupts the physiological reg- rimonabant (CB1 cannabinoid receptor antagonist) was also withdrawn ulation of body weight. Where lifestyle changes have not yielded results due to its association with depression and suicide (Arch, 2015; Fujioka, and, due to the risks associated with this condition, some cases have 2015). -
Targeting Quorum Sensing
Supporting information Targeting Quorum Sensing: High-Throughput Screening to Identify Novel LsrK Inhibitors Viviana Gatta 1, Polina Ilina1, Alison Porter 2, #, Stuart McElroy 2,# and Päivi Tammela 1,* 1 Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, FI-00014 Helsinki, Finland; [email protected] (V.G.), [email protected] (P.I.), [email protected] (P.T.) 2 European Screening Centre, Biocity Scotland, Newhouse, ML1 5UH, UK; [email protected] (A.P.), [email protected] (S.M.) * Correspondence: [email protected]; Tel.: +358-50-448 0886 # Current address: BioAscent Discovery Ltd., Newhouse ML1 5UH, UK; [email protected] (A.P.); [email protected] (S.M.) Table of contents: Assay development………………………………………………………………………………………...page 2 Results from primary screening…………………………………………………………………………..page 2-85 Dose-response experiments……………………………………………………………………….............page 86-89 Thermal shift assay and MST assay………………………………………………………………………page 90-91 AI-2 quorum sensing interference activity………………………………………………………………page 92 1 Figure S1: Optimization of LsrK and DPD concentrations: (a) S/B and (b) Z’ calculated for each tested combination of LsrK and DPD. Table S1. LsrK inhibition results from primary screening of the MicroSource Spectrum Library. Bioactivity and source refer to information provided as MicroSource annotations. Compounds were tested in singles at 50 µM, and sorted in the table according to their inhibitory effect.